Brought to you by 
Atritech closes $30mm round
02 Jun 2009
Executive Summary
Medical device company Atritech raised $30mm through a late-stage venture round led by Thomas, McNerney & Partners. Split Rock Partners, Prism Ventures, Tullis-Dickerson, and Vector Group also participated in the financing. The company will use the funds to complete FDA review and then market launch of its Watchman closure device, designed to prevent stroke-causing blood clots from entering the circulatory system in patients with atrial fibrillation. The PROTECT AF clinical trials are comparing the device to warfarin drug treatment, the current standard of care.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Atritech closes $30mm round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice